Clinical Foundation
Research & Evidence
Every treatment we offer is backed by peer-reviewed clinical research. Here's the evidence behind our approach.
The first and only FDA-cleared IPL device specifically for dry eye treatment. Cleared in 2021 based on robust clinical evidence demonstrating significant improvement in dry eye signs and symptoms.
View source →IPL efficacy for dry eye and meibomian gland dysfunction has been validated across 13+ RCTs, including Peira 2025 showing −16 OSDI improvement vs. placebo. Zero serious adverse events reported across all published RCTs.
View source →Six independent meta-analyses confirm IPL efficacy for MGD and dry eye. Results demonstrate consistent improvements in tear breakup time, meibomian gland secretion quality, and patient-reported symptom scores.
View source →Evidence-Based Treatment
Our commitment to clinical evidence means every treatment protocol is grounded in published research. We believe in transparency — ask us about any study behind our recommendations.
Ask About Our Research